Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe by Habre, Walid et al.
www.thelancet.com/respiratory   Published online March 28, 2017   http://dx.doi.org/10.1016/S2213-2600(17)30116-9 1
Articles
Incidence of severe critical events in paediatric anaesthesia 
(APRICOT): a prospective multicentre observational study in 
261 hospitals in Europe 
Walid Habre, Nicola Disma, Katalin Virag, Karin Becke, Tom G Hansen, Martin Jöhr, Brigitte Leva, Neil S Morton, Petronella M Vermeulen, 
Marzena Zielinska, Krisztina Boda, Francis Veyckemans, for the APRICOT Group of the European Society of Anaesthesiology Clinical Trial Network*
Summary
Background Little is known about the incidence of severe critical events in children undergoing general anaesthesia 
in Europe. We aimed to identify the incidence, nature, and outcome of severe critical events in children undergoing 
anaesthesia, and the associated potential risk factors.
Methods The APRICOT study was a prospective observational multicentre cohort study of children from birth to 
15 years of age undergoing elective or urgent anaesthesia for diagnostic or surgical procedures. Children were eligible 
for inclusion during a 2-week period determined prospectively by each centre. There were 261 participating centres 
across 33 European countries. The primary endpoint was the occurence of perioperative severe critical events 
requiring immediate intervention. A severe critical event was defined as the occurrence of respiratory, cardiac, 
allergic, or neurological complications requiring immediate intervention and that led (or could have led) to major 
disability or death. This study is registered with ClinicalTrials.gov, number NCT01878760.
Findings Between April 1, 2014, and Jan 31, 2015, 31 127 anaesthetic procedures in 30 874 children with a mean age of 
6·35 years (SD 4·50) were included. The incidence of perioperative severe critical events was 5·2% (95% CI 5·0–5·5) 
with an incidence of respiratory critical events of 3·1% (2·9–3·3). Cardiovascular instability occurred in 1·9% 
(1·7–2·1), with an immediate poor outcome in 5·4% (3·7–7·5) of these cases. The all-cause 30-day in-hospital 
mortality rate was 10 in 10 000. This was independent of type of anaesthesia. Age (relative risk 0·88, 95% CI 0·86–0·90; 
p<0·0001), medical history, and physical condition (1·60, 1·40–1·82; p<0·0001) were the major risk factors for a 
serious critical event. Multivariate analysis revealed evidence for the beneficial effect of years of experience of the 
most senior anaesthesia team member (0·99, 0·981–0·997; p<0·0048 for respiratory critical events, and 0·98, 
0·97–0·99; p=0·0039 for cardiovascular critical events), rather than the type of health institution or providers.
Interpretation This study highlights a relatively high rate of severe critical events during the anaesthesia management 
of children for surgical or diagnostic procedures in Europe, and a large variability in the practice of paediatric 
anaesthesia. These findings are substantial enough to warrant attention from national, regional, and specialist 
societies to target education of anaesthesiologists and their teams and implement strategies for quality improvement 
in paediatric anaesthesia.
Funding European Society of Anaesthesiology.
Introduction
Guidelines for paediatric anaesthesia management and 
structured programmes for specific training have been 
developed in Europe during the past decade to standardise 
practice and improve patient safety. The incidence, 
nature, and outcome of severe critical events in children 
during and immediately after anaesthesia in Europe, and 
the effects of variability in practice are unknown. Most of 
the literature on paediatric anaesthesia morbidity and 
mortality comprises clinical audits focusing on a single 
institution or country,1–3 which were not sufficiently 
powered to study rare, severe complications or mortality.4 
Moreover, differences in study design and in the 
definitions of severe complications make comparisons 
between the studies problematic.
In 2014, a large North American register was initiated 
as part of a safety and quality improvement programme 
that revealed an incidence of severe critical events in 
paediatric anaesthesia of 0·14%.5 This finding is in line 
with previous reports from single centres or countries, 
the findings of which show that the rate of major 
perioperative complications causing severe morbidity, 
mortality, or both, after general3,6 or regional anaesthesia,7–10 
is low. Most studies have highlighted respiratory 
complications as the primary cause of severe adverse 
outcome following sedation or general anaesthesia in 
children.11–13 Other publications have pointed out a 
significant increase in haemodynamic-related severe 
critical events as a consequence of bleeding or inadequate 
fluid management.5,14 Although most of these studies 
attempted to identify major risk factors (such as age 
<1 year, the presence of comorbidities, and specific 
surgical procedures), identification of predictable and 
preventable risks is of paramount importance as the basis 
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for implementation of paediatric practice standards to 
improve the quality and safety of anaesthesia for children 
throughout Europe.
This prospective observational multicentre cohort study 
was designed to identify the incidence and nature of 
severe critical events and their outcomes in children 
undergoing any type of anaesthesia in Europe. These 
events were defined as the occurrence of respiratory, 
cardiac, allergic, or neurological complications requiring 
immediate intervention and that led (or could have led) to 
major disability or death. We also aimed to identify the 
risk factors contributing to these severe critical events, 
and to describe the variations in paediatric anaesthesia 
practice throughout Europe.
Methods
Study design
We prospectively collected perioperative data that 
described the anaesthesia management of consecutive 
children admitted to 261 participating centres across 
33 European countries. Children were recruited during 
a consecutive 2-week period, which was determined 
in advance by each participating centre, between 
April 1, 2014, and Jan 31, 2015. Patients were followed 
for up to 60 min after anaesthesia or sedation, and the 
child’s status at discharge or at 30 days, if still in 
hospital, was reported. All children from birth to 
15 years of age undergoing an inpatient or outpatient 
diagnostic or surgical procedure, whether elective, 
urgent or emergency, in-hours or out-of-hours, under 
sedation or general anaesthesia, with or without 
regional analgesia, or under regional anaesthesia alone, 
were eligible for inclusion. Children were excluded 
from the study if they were aged 16 years and older, were 
admitted directly to the operating room already 
intubated, or anaesthesia procedures were done in the 
neonatal or paediatric intensive care unit.
Participating investigators registered on a voluntary 
basis through a call for centres sent to active members of 
the European Society of Anaesthesiology (ESA) and the 
European Society for Paediatric Anaesthesiology (ESPA). 
Ethics requirements differed among countries and even 
within a given country. All participating centres applied 
for formal ethics approval or a waiver, as appropriate 
(appendix p 1).
Procedures
Before starting to recruit patients, each local investigator 
provided details of their hospital’s paediatric anaesthesia 
activity, perioperative care facilities, annual number of 
procedures, and the number of certified or dedicated 
anaesthesiologists for paediatric practice. Data obtained 
from the recruited children were collected on data 
acquisition sheets, which were then entered anonymously 
on a secure internet-based electronic case record form 
(OpenClinica, Boston, MA, USA).
Research in context
Evidence before this study
There is no clear information about the morbidity and 
mortality associated with anaesthesia management in children 
in Europe. We used the MeSH terms “morbidity”, “mortality”, 
“severe complications”, “adverse events”, “children”, 
“anaesthesia”, and “perioperative”, to search MEDLINE and we 
limited the results to include studies done in Europe only. 
Most studies about paediatric anaesthesia morbidity and 
mortality that have been published between Jan 1, 1971, and 
Jan 1, 2014, are the results of clinical audits focusing on a single 
institution or country.
Moreover, studies focusing on adverse events in the perioperative 
period have used a variety of definitions for the occurrence of 
severe adverse events, which makes any benchmarking 
comparison difficult. Although respiratory complications were 
considered to be the primary cause of perioperative complications 
in Europe, reports from outside Europe suggested a significant 
increase in haemodynamic-related severe adverse events leading 
to poor outcomes, such as perioperative cardiac arrest. A registry 
in the USA included morbidity and mortality data from larger 
specialist institutions and has confirmed the evolving role of 
cardiovascular events in these outcomes while documenting a 
rate of serious adverse perioperative events of approximately 
0·14%. Age, comorbidities, and physical status of the child have 
been recognised as risk factors.
Added value of this study
Our study was prospective, multicentre, multinational, and 
pan-European in scope, and we used detailed definitions of severe 
critical events. The critical events were captured with a high degree 
of fidelity in a large cohort of paediatric cases from a range of 
institutions. A high rate of severe critical events was revealed, with 
a large variable incidence across Europe. The nature of events and 
their outcomes are described in detail. We identified new risk 
factors for severe critical events, including inexperience of the 
anaesthesiology team, especially in the management of the 
youngest and most ill patients. The discovery of widely variable 
clinical practice among the participating centres in Europe, and 
even within countries, advocates for the establishment of a 
European register to monitor peri-anaesthetic morbidity and 
mortality in children. A cutoff age of 3 years was estimated, below 
which children should be managed by more specialist services to 
reduce risk of adverse events and improve outcomes.
Implications of all the available evidence
These findings warrant attention from national, regional, 
and specialist scientific societies, and provide a basis to identify 
areas for further training, clinical research, and for quality 
improvement initiatives. Moreover, some centralisation of care 
for the youngest and most ill infants is needed to allow access 
to more experienced health-care teams to reduce the adverse 
event rate and improve outcomes.
See Online for appendix
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All severe critical events, including their time of 
occurrence (during anaesthesia induction, mainten-
ance, or emergence, or in the post-anaesthetia care 
unit), the treatment needed, and the immediate out-
come were documented. These severe critical events 
included all episodes of laryngospasm, bronchospasm, 
pulmonary aspiration, drug error, anaphylaxis, cardio-
vascular in stability, neurological damage, perioperative 
cardiac arrest, and the occurrence of stridor at emer-
gence from anaesthesia or in the post-anaesthesia 
care unit.
We defined the primary endpoint as the occurrence of 
any severe critical event requiring immediate intervention 
that led, or could have led, to major disabilities or death. 
Secondary outcome measures were the potential con-
sequences of those severe critical events (ie, no harm, 
minor sequelae, major sequelae, in-hospital mortality) at 
discharge from the hospital or at 30 days post-anaesthesia 
or sedation.
Full details of the patient history, type of procedure, 
anaesthetic and airway management, regional analgesia, 
the experience of the anaesthetic team in charge, and 
postoperative care (up to 60 min) were also recorded 
(appendix p 2–4).
Statistical analysis
On the basis of the largest retrospective study in a referral 
centre in Europe,3 and considering the probability of 
occurrence of any of the severe critical events studied as a 
primary endpoint, we anticipated that a minimum of 
approximately 25 000 patients would provide a 95% CI for 
the overall incidence of severe critical events with an 
acceptable confidence width assuming that the lowest 
incidence of severe critical events is 0·1%, (ie, 95% exact 
CI is 0·065–0·147). We identified a similar minimum 
number of subjects when estimating the sample size on 
the comparisons between institutions. We defined an a 
priori detailed statistical analysis plan in the initial 
protocol.
We did statistical analysis with SPSS (version 24) and 
SAS (version 9.4) statistical software. Data are expressed 
as mean (SD) for continuous variables and percentages 
for categorical variables. Univariate and multivariate 
methods were used to test factors associated with the 
endpoints. We used these methods on all available data 
and when all risk factors were present. We considered 
that multiple procedures were sometimes done on the 
same individuals, so we did univariate analysis with a 
generalised linear model, using binomial distribution 
for the dependent variable, log-link function, and un-
structured covariance structure for correlated obser-
vations. We estimated univariate relative risks (RRs) 
and 95% CIs from the model.
We did receiver operating characteristic analysis, using 
age as a continuous variable, to identify a cutoff age 
where the overlap of the distribution of ages with and 
without a complication was minimal.
We did multivariate analyses with a hierarchical RR 
regression model with log-link function and binomial 
dependent variable, taking the participating centre as a 
random factor. To avoid multicollinearity, we examined 
correlations between the independent variables by 
factor analysis with principal component method, and 
by correspondence analysis. The factor analysis showed 
that grouping some variables were in line with the 
medical and clinical considerations. We collapsed 
mostly correlated binary or dichotomised categorical 
variables into one variable using the OR logical 
operator. We used these collapsed variables in the 
multivariate analyses with the remaining nominal and 
continuous variables. Some variables, which were 
clearly insignificant by the univariate methods or not 
medically meaningful, were not included in the 
multivariate models. We tested medically plausible 
interactions and model fit, and we calculated estimated 
RRs with 95% CIs and p values. Despite the collapsed 
variables, multivariate models did not include all cases, 
so we compared all covariates for complete cases and 
for groups with missing data by descriptive statistics. 
In all cases, we used two-sided tests.
This study is registered with ClinicalTrials.gov, number 
NCT01878760.
Role of the funding source
The funding source provided the infrastructure for 
the trial, identified the national study coordinating 
investigators, liaised with the local investigators re-
garding their ethics submission process and the 
inclusion period, and monitored the data entry and 
cleaning. WH, FV, KV, BL, and KB had access to the 
raw data. The corresponding author had full access 
to all the data in the study and had the final 
responsibility for the decision to submit the manuscript 
for publi cation.
Results
The final APRICOT exported dataset, dated March 24, 
2016, included 30 874 participants and 31 127 anaesthetic 
procedures, with 188 children having more than 
one anaesthetic procedure during the 2-week inclusion 
period (from two to ten anaesthetic procedures; 
figure 1). The dataset represented 88% of all procedures 
done in the participating centres during the 2-week 
inclusion period (appendix p 1).
The mean age of the enrolled children was 6·35 years 
(SD 4·5) comprising 361 (1·2%) neonates, 2912 (9·4%) 
infants (aged 28 days to 1 year-old), 13 463 (43·6%) pre-school 
children (1–5 years), 9229 (29·9%) schoolchildren 
(6–12 years), and 4908 (15·9%) adolescents (13–15 years). 
The age (but not the weight) of one child was not reported. 
A history of prematurity was reported in 2344 (7·6%) of the 
children with a mean gestational age at birth of 32·3 weeks 
(SD 3·5) weeks, but these data were missing in 11% (n=3461) 
of cases.
For more on the definition of 
critical events see http://www.
esahq.org/research/clinical-trial-
network/ongoing-trials/apricot/
documents
For the protocol and case report 
form see http://www.esahq.org/
research/clinical-trial-network/
ongoing-trials/apricot/
documents
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Applying receiver operating characteristic analysis with 
age showed a threshold cutoff age of 3·77 years for the 
occurrence of severe critical events, when the sum of 
sensitivity and specificity was at a maximum.
Table 1 lists the American Society of Anesthesiology 
Physical Status (ASA-PS) distribution of the patients, and 
patient characteristics and relevant medical history are 
summarised in the appendix (p 2).
Details of the anaesthesia plans and the scheduled 
times of the procedures are shown in the appendix 
(pp 3–4). 40 different drug combinations were used for 
premedication, and 100 different drug combinations 
were used for induction of anaesthesia. Inhalational 
induction was used in younger children (mean age 
4·87 years [SD 3·8]) compared with intravenous in-
duction (7·99 [4·6]; p<0·001). Indication, mean age, and 
outpatient and inpatient distribution, as well as the 
schedule type of all procedures performed, are shown 
in the appendix (pp 5–6). The composition of the 
anaesthesia team taking care of the child during the 
procedures is also shown (appendix p 7).
1478 children (4·8%) had severe critical events. The 
total number of reported severe critical events occurring 
during or immediately after anaesthesia was 1637 (5·3% 
of the 31 127 procedures), with 1335 children having 
one severe critical event, 127 children having two, 
14 children having three, and two having four. The 
estimated incidence of perioperative severe critical events 
was 5·2% (95% CI 5·0–5·5). This incidence was 
significantly higher during general anaesthesia than 
under sedation (RR 2·69, 95% CI 1·38–5·26; p<0·0001), 
and was lower when anaesthesia was done outside of the 
operating room (eg, MRI, radiotherapy) than when 
inside (RR 0·57, 0·47–0·70; p<0·0001). Of the reported 
severe critical events, 283 (17·3%) of 1637 resulted in 
additional post-anaesthesia treatments, prolonged treat-
ment in hospital, or both.
Tables 2–4 summarise the incidence of respiratory 
severe critical events (laryngospasm, bronchospasm, 
bronchial aspiration, and post-anaesthesia stridor), 
cardio vascular severe critical events, drug errors and 
their time of occurrence, the applied treatments, and 
the immediate outcome.
The incidence of severe laryngospasm was 1·2% 
(95% CI 1·1–1·3) and of bronchospasm, 1·2% (1·1–1·3). 
Bronchial aspiration was reported in 29 patients (with 
two having episodes at two different times of the 
anaesthesia), corresponding to an inci dence of 9·3 per 
10 000 cases or 0·1% (0·06–0·13). Finally, the incidence 
of post-anaesthetic stridor was 0·7% (0·6–0·8) for the 
whole population studied, and 1·1% (0·9–1·3) for those 
who had undergone tracheal intubation. The incidence 
of cardiovascular instability requiring an intervention 
was 1·9% (95% CI 1·7–2·0). In 32 (5·5%) of the cases, 
the outcome was poor: haemo dynamic instability 
resulted in cardiac arrest in eight patients, coagulopathy 
in 19, and rescue treat ments (extracorporeal membrane 
oxygenation, re-operation, etc) in nine others.
Ten episodes of cardiac arrest occurred in nine patients 
out of 30 874, or 0·03% (95% CI 0·01–0·05; table 5). 
Hypoxaemia was the plausible cause for cardiac arrest 
in four cases, while low cardiac output occurred in 
four patients, and hypotension in two others. None of the 
children died during the perioperative period but at 
30 days, three children had died and three others were 
still in hospital.
The incidence of drug errors (eg, wrong dose, drug, or 
site of administration) was 49 (0·2%, 95% CI 0·1–0·2) 
(table 4). Drug error (epinephrine) led to a severe 
immediate adverse outcome in one patient.
Figure 2 shows the distribution of the main respiratory 
and cardiovascular critical events according to age 
category. The incidence of cardiovascular and respiratory 
critical events was significantly higher in neonates 
(0–1 month) and infants (1 month to 1 year), with 
neonates having the highest rate of cardiovascular 
complications (12·1%, 95% CI 8·9–15·9; p<0·0001).
Severe critical events occurred significantly more 
frequently with increasing ASA risk category: ASA I, 
3·5% (95% CI 3·2–3·7); ASA II, 5·7% (5·0–5·7); ASA III, 
9·0% (8·0–10·0); ASA IV and V, 15·0% (12·1–18·5); 
overall p<0·0001.
372 centres from 36 countries recruited
263 centres from 33 countries included
261 centres from 33 countries; 
30 878 participants included
31 131 procedures
30 874 participants and 31 127 procedures analysed
109 centres excluded
Staff shortage for research and consent
Difficulties dealing with ethics boards
3791 screening failure
200 patients excluded
2 centres not eligible (150 patients)
29 informed consent not obtained
7 data lost
14 patients not meeting inclusion 
criteria
29 145 queries sent to centres
28 253 queries resolved
62 subjects with two occurrences 
by mistake
4 patients excluded because age 
was missing
74 patients listed erroneously as 
having complications
Figure 1: APRICOT trial profile
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The incidence of severe critical events significantly 
differed between the anaesthesia teams only when 
individuals in ASA-PS III, IV, and V were grouped: 
compared with dedicated providers, the incidence was 
1·34-times higher for frequent providers (RR=1·34, 95% CI 
1·00–1·79; p=0·051), and 1·48-times higher for occasional 
providers (1·48, 1·11–1·96; p=0·007). This difference was 
only evident for cardiovascular critical events, where the 
risk was higher for frequent providers (1·47, 1·03–2·09; 
p=0·035) and for occasional providers (1·79, 1·29–2·50, 
p=0·001), compared with dedicated providers.
Table 5 describes the details of the patients who had a 
neurological event, with an incidence of 1·6 per 
10 000 cases or 0·02% (95% CI 0·002–0·03), and those 
with anaphylaxis, with an incidence of 1 per 10 000 cases 
or 0·01% (0·002–0·025). No neurological critical events 
were reported after regional analgesia, and most of the 
others could not be related to anaesthesia management.
Figure 3 illustrates the incidence of severe critical 
events occurring in the participating centres across 
33 European countries, and the relative contribution of 
respiratory and cardiovascular complications to the total 
incidence of severe critical events in each country. We 
observed a large range (0·4–13·3%) for the incidence of 
severe respiratory critical events (0·2–6·7% for 
laryngospasm, 0·3–3·2% for bronchospasm, 0·3–6·7% 
for stridor, and 0·1–0·4% for bronchial aspiration), 
cardiovascular critical events (0·2–6·7%), and for the 
incidence of the other events (0·1–4·4 %).
After univariate and multivariate analyses, age (con-
sidered as a continuous variable) was a risk factor for 
respiratory critical events (table 6), with a decreased risk of 
12% for respiratory severe critical events for each increasing 
year of age. Univariate analysis revealed that history of 
prematurity increased the relative risk for the occurrence of 
these respiratory complications by a factor of almost two 
(table 6). Multivariate analysis with collapsed variables 
n (%) Mean age (SD), 95% CI Anaesthesia team, n (%)
Specialist 
anaesthesiologist 
with mainly (>80%) 
paediatric cases
Specialist 
anaesthesiologist 
with frequent 
(50–80%) paediatric 
anaesthesia cases 
Specialist 
anaesthesiologist 
with occasional 
(<50%) paediatric 
anaesthesia cases 
Anaesthesiologist in 
training, anaesthetic 
nurse, or technician
ASA I 18 883 (60·7%) 6·6 (4·4), 6·5–6·6 10 182 (53·9%) 2863 (15·2%) 4234 (22·4%) 1601 (8·5%)
ASA II 8739 (28·1%) 6·2 (4·6), 6·1–6·3 5629 (64·4%) 1128 (12·9%) 1374 (15·7%) 608 (7·0%)
ASA III 2987 (9·6%) 5·6 (4·7), 5·5–5·8 2149 (72·0%) 318 (10·6%) 315 (10·6%) 204 (6·8%)
ASA IV 498 (1·6%) 4·4 (4·6), 4·0–4·8 393 (78·9%) 48 (9·6%) 44 (8·8%) 13 (2·6%)
ASA V 12 (0·04%) 1·5 (3·2), –0·5 to 3·6 11 (91·7%) 1 (8·3%) 0 (0·0%) 0 (0·0%)
Total 31 119 (100%) 6·3 (4·5), 6·3–6·4 18 364 (59·0%) 4358 (14·0%) 5967 (19·2%) 2426 (7·8%)
Values missing for eight procedures. ASA I: normal healthy patient. ASA II: mild systemic distress. ASA III: severe systemic distress. ASA IV: severe systemic distress that is a 
constant threat to life. ASA V: moribund patient who is not expected to survive without surgical intervention. ASA=American Society of Anesthesiologists.
Table 1: Mean patient age in years (standard deviation; 95% confidence interval) and distribution among anaesthesia teams according to ASA physical 
status
Laryngospasm 
(n=368)
Bronchospasm 
(n=371)
Bronchial 
aspiration 
(n=29)
Stridor 
(n=208)
Time of occurrence, n (%)
Induction 132 (35·0%) 118 (29·5%) 13 (41·9%) ..
Maintenance 69 (18·2%) 99 (24·7%) 8 (25·8%) ..
Awakening 165 (43·6%) 167 (41·7%) 8 (25·8%) 157 (70%)
Post-anaesthesia care unit 12 (3·2%) 16 (4·0%) 2 (6·5%) 67 (30%)
Treatment, n (%)
Propofol 255 (52·5%) .. .. ..
Succinylcholine 69 (14·2%) .. .. ..
Intubation/prolonged 
intubation
73 (15·1%) 56 (12·1%) 4 (9·3%) ..
Bronchodilators .. 224 (48·3%) 13 (30·2%) ..
Epinephrine .. 19 (4·1%) .. 54 (23·3%)
Deepening anaesthesia .. 85 (18·3%) .. ..
Bronchotracheal suction .. .. 23 (53·5%) ..
Antibiotics .. .. 2 (4·7%) ..
CPAP .. .. 1 (2·3%) 84 (36·2%)
Intravenous steroids .. .. .. 31 (13·4%)
Other treatments 88 (18·1%) 80 (37·3%) .. 63 (27·1%)
Outcome, n (%)
Uneventful 358 (97·1%) 216 (57·0%) 18 (54·6%) 198 (95·2%)
Intubation/prolonged 
intubation
9 (2·4%) 11 (2·9%) 4 (12·1%) 9 (4·3%)
Pulmonary oedema 1 (0·3%) .. .. ..
Hypoxaemia .. 145 (38·3%)* 10 (30·3%) ..
Admission to intensive care unit .. 2 (0·5%) .. ..
Pneumonia .. .. 1 (3·0%) ..
Tracheostomy .. .. .. 1 (0·5%)
Other .. 5 (1·3%) .. ..
Data are n (%); there were some repeated events. Airway interventions include application of CPAP, PEEP, or oxygen. 
CPAP=continuous positive airway pressure. PEEP=positive end-expiratory pressure.*Hypoxaemia defined as oxygen 
saturation less than 90%. 
Table 2: Time of occurrence, treatment, and outcome of perioperative respiratory severe critical events
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revealed that the presence of sensitised airways (defined as 
airways with acute or chronic inflammation) and physical 
condition (prematurity, fever, handicap, snoring, medi-
cation, or ASA-PS >2) are important risk factors for the 
occurrence of respiratory severe critical events (table 6).
Although there was no evidence for an effect of the type 
of health institution or anaesthesia team on the 
occurrence of respiratory severe critical events, we found 
weak evidence for the potential protective role of an 
experienced anaesthesiologist (1% decrease in occurrence 
per year of experience; table 5). Both inhalation induction 
and airway management (use of endotracheal tube, 
supraglottic airway, or both) were significantly associated 
with a higher risk of respiratory severe critical events.
Table 7 summarises the risk factors for cardiac severe 
critical events. The risk was significantly higher for surgical 
procedures compared to non-surgical pro cedures, specific-
ally cardiac surgery (RR 16·92 [95% CI 13·67–20·93]) and 
cardiac catheterisation (3·20 [1·71–5·85]). Multivariate 
analysis con firmed the signifi cant effect of physical con-
dition and the pro tective role of an experienced anaes-
thesiologist (2% decrease in risk of cardiac severe critical 
events per year of experience; table 7).
Considering the low occurrence of other critical events 
(ie, anaphylaxis, neurological events, drug errors, and 
bronchial aspiration), identifying risk factors in a 
univariate and multivariate analysis was only possible 
for bronchial aspiration (appendix, p 8), which occurred 
more frequently in emergency situations (RR 8·43 
[95% CI 1·97–36·10]).
There were 38 participating centres from 14 countries 
that did not report any severe critical events. A subgroup 
analysis revealed that children included from these 
centres were significantly older, were more likely to be 
normal healthy patients (ASA-PS I), fewer had a history 
of prematurity and handicap, fewer underwent tracheal 
intubation, and more were managed by more 
experienced anaesthesiologists (p<0·001; data not 
Severe cardiovascular events 
(n=549) 
Time of occurrence, n (%)* 
Induction 143 (21·9%)
Maintenance 454 (69·4%)
Awakening 32 (4·9%)
Post-anaesthesia care unit 25 (3·8%)
Type of event,n (%)† 
Bleeding 112 (16·0%)
Arrhythmia (all) 136 (19·5%)
Arrhythmia (bradycardia) 86 (12·3%)
Arrhythmia (ventricular tachycardia) 2 (0·3%) 
Arrhythmia (ventricular fibrillation) 1 (0·2%) 
Hypotension 384 (54·9%)
Vasodilation 37 (5·3%)
Hypertension 7 (1·0%)
Cardiac dysfunction 4 (0·7%)
Myocardial ischaemia 2 (0·3%)
Miscellaneous 14 (2·0%)
Treatment, n (%)‡ 
Fluid resuscitation 316 (33·7%)
Blood products 124 (13·3%)
Fluids and blood products§ 29 (3·1%) 
Vasopressors 301 (32·4%)
Fluids/blood products and 
vasopressors§
185 (19·7%)
Atropine 138 (14·7%)
Defibrillation 8 (0·9%)
Other treatments 51 (5·5%)
Outcome, n (%)¶
Uneventful 560 (94%)
Cardiac arrest 8 (1·3%)
Coagulopathy 19 (3·2%)
Extracorporeal membrane 
oxygenation
2 (0·3%) 
Myocardial ischaemia 1 (0·2%) 
Admission to intensive care unit 5 (0·8%) 
Reoperation for haemostasis 2 (0·3%) 
Data are n (%).*n=654. †n=696. ‡n=938. §Subgroup of children who received 
both interventions for cardiovascular critical events. ¶n=597.
Table 3: Time of occurrence, type of severe cardiovascular critical events, 
treatment applied, and outcome
Drug errors (n=49)
Time of occurrence, n (%)*
Induction 22 (44%)
Maintenance 22 (44%)
Awakening 5 (10%)
Post-anaesthetic care unit 1 (2%)
Type of events, n (%)
Wrong dose 29 (59·2%)
Wrong drug 8 (16·3%)
Wrong site of administration 12 (24·5%)
Wrong site of femoral block 1 (2·0%)
Subcutaneous administration of drugs 7 (14·0%)
Fluid extravasations 4 (8·0%)
Treatment, n (%)
None 42 (85·7%)
Naloxone 5 (10·2%)
Diuretics 1 (2·0%)
Fluid resuscitation 1 (2·0%)
Outcome, n (%)
No sequelae 16 (32·7%)
Minor sequelae 32 (65·3%)
Major sequelae† 1 (2·0%)
*For one patient, drug error was reported during induction and maintenance and 
for another, during maintenance and awakening. †Patient was admitted to the 
intensive care unit after receiving epinephrine instead of atropine with 
neostigmine. 
Table 4: Time of occurrence, type of drug error, treatment applied, and 
outcome
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shown). Thus, a Spearman rank correlation analysis 
was done on the subgroup of patients included in the 
223 centres that reported any severe critical events to 
characterise a potential relationship between the 
incidence of severe critical events and the number of 
patients recruited from each centre. There was some 
evidence for a lower incidence of respiratory and 
cardiovascular severe critical events in the centres with 
high caseload (appendix p 9).
24 789 (80·3%) patients were admitted to the post-
anaesthesia care unit (recovery room), while 4040 (13·1%) 
were sent directly to the ward. 603 (1·9%) children were 
admitted to an intermediate care unit, and 1435 (4·7%) 
were admitted to an intensive care unit. Oxygen was 
delivered systematically in 43·7% of cases. The mean 
duration of stay was 2·1 h (SD 23·0) hours in the 
post-anaesthesia care unit, 1·1 days (3·9) in the 
intermediate care unit, and 4·3 days (7·5) in the intensive 
care unit.
Status at 30 days post-anaesthesia or post-sedation was 
available in 29 094 cases. 27 943 children were discharged 
home (96%), with 305 (1·1%) sent to a convalescent 
centre, and 171 (0·6%) to an acute centre; 640 (2·2%) 
patients were still in hospital.
Age ASA 
category
Procedure Timing Clinical signs Perioperative 
severe adverse 
event
Plausible cause Treatment Outcome Status at 
30 days
Children with perioperative cardiac arrest (n=9)
Case 1 8m II Trauma Maintenance ·· Hypotension, 
hypoxaemia
Displacement 
endotracheal tube 
during endoscopic 
thoracic surgery, severe 
hypoxaemia, and 
hypotension 
CCM, atropine, 
ephedrine, 
re-intubation
Uneventful Discharged 
home
Case 2 4y 6m II ENT PACU ·· Hypoxaemia Pneumothorax under 
tension (closure 
tracheostomy)
CCM, 
epinephrine
Uneventful Still in 
hospital
Case 3a 4y 3m IV Cardiac 
catheterism 
(eg, DORV, VSD, 
ASD, pulmonary 
stenosis)
Induction
(ketamine)
·· Arrhythmia, 
hypotension
Low cardiac output at 
induction
CCM, 
epinephrine
Recovered; 
admitted to ICU 
for 24 hours
Death from 
cardiopathy
Case 3b 4y 3m V Cardiac surgery Induction
(etomidate 
and 
ketamine)
·· Arrhythmia, 
hypotension
Low cardiac output at 
induction from 
complex cardiopathy
CCM, OCM, 
defibrillation, 
epinephrine, 
calcium, 
bicarbonate
Bypass in urgent 
situation; 
admitted to ICU 
(for 19 days)
Death from 
cardiopathy
Case 4 14y 8m II Trauma Maintenance ·· Hypoxaemia, 
haemodynamic 
instability, 
bradycardia
Trachea blocked by 
endobronchial blocker
CCM, atropine Uneventful Discharged 
home
Case 5 1m II Gastrointestinal 
surgery
Induction ·· Severe hypoxaemia 
(SpO₂<85% for 
>2 min), bradycardia, 
asystole
Difficult ventilation; no 
intubation
CCM, 
epinephrine
Haemodynamic 
instability; 
neurological 
controls normal
Discharged 
home
Case 6 5d IV Cardiac surgery Maintenance ·· Haemodynamic 
instability
Norwood operation CCM, 
defibrillation, 
extracorporeal 
membrane 
oxygenation
Multiple organ 
failure and 
death
Death
Case 7 10y 10m V Gastrointestinal 
surgery
Induction
(rapid 
sequence 
induction 
with 
propofol-
atracurium)
·· Bleeding, 
hypotension, 
transfusion
·· CCM, 
epinephrine, 
phenylephrine
Death from 
sepsis
Death
Case 8 2m III Gastroenterology 
endoscopy
Induction ·· Hypotension,
severe hypoxaemia 
(SpO₂ about 60%)
Cardiac dysfunction in 
a complex patient; low 
cardiac output
CCM, 
epinephrine, 
phenylephrine
Uneventful Still in 
hospital
Case 9 29d; 
born at 
36 weeks
IV Thoracic Maintenance ·· Hypotension, 
bradycardia
Under ACE inhibitors 
for coarctation
CCM, atropine Uneventful Discharged to 
acute centre 
(Table 5 continues on next page)
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The overall mortality rate at 30 days was 30, or 0·1% 
(95% CI 0·07–0·14). None of the reported deaths were 
anaesthesia-related. Sepsis was reported as the most 
frequent cause of death (eight patients), while multiple 
organ failure (three), congenital ab normalities (three), 
viral encephalitis (four), con genital heart disease 
(three), respira tory distress syn drome (two), haemato-
logical dis eases (two), chemo therapy-associated lung 
haemorrhage (one), pul monary embolism (one), and 
epidermolysis bullosa (one) were also reported. For 
two cases the cause of death was unknown.
Discussion
We did a large prospective multicentre cohort study to 
determine the incidence and nature of severe critical 
events in children undergoing anaesthesia in Europe. 
The results show a large variability across the partici-
pating centres in 33 European countries. Respiratory-
related severe critical events were the most frequent 
com plications reported in all age groups, whereas 
cardio vascular incidents were pre dominantly re ported 
in neonates and infants. Although the outcome of 
most severe critical events was uneventful, additional 
treatment strategies or prolonged hospital isation was 
needed in one in six patients who had a critical event. 
Large variations in paediatric anaesthesia practice in 
Europe were documented, highlighting the urgent 
need for more widespread implementation of good 
clinical practice guidelines and standards of paediatric 
anaesthesia management across Europe.
The design of this study was an anonymised 
observational audit of current paediatric anaesthesia 
practice, with anaesthesia management left entirely at 
the discretion of the health-care provider. Local ethics 
committees differed in their opinion regarding the 
need for individual written parental informed consent, 
and thus we were unable to include all children 
anaesthetised during each 2-week inclusion period, 
since permission was not sought from or given by 
some parents to include their child’s data. However, 
data were available for 89% of children anaesthetised 
within 2 weeks at 261 institutions, with a balanced 
distri bution between hospital categories and anaes-
thesiologists. There were very few missing values, 
Age ASA 
category
Procedure Timing Clinical signs Perioperative 
severe adverse 
event
Plausible cause Treatment Outcome Status at 
30 days
(Continued from previous page)
Children with neurological symptoms (n=5) 
Case 1 7y 10m III ·· Awakening Seizures ·· Known complex 
epilepsy; seizure at 
extubation
Barbiturates Seizures Discharged 
home
Case 2y 5m III ·· Induction Transient seizures 
during sevoflurane 
induction
·· Not related to 
anaesthesia; patient 
with leukaemia on 
vincristine therapy
None Uneventful Discharged 
home
Case 3 7y 1m IV ·· Awakening Loss of motor 
movements after 
scoliosis surgery 
with difficult 
interpretation of 
somatosensory 
evoked potential
·· Not related to 
anaesthesia
Reoperation 
with 
decompressive 
laminectomy
No neurological 
deficit
Still in 
hospital
Case 4 14y 5m II ·· Maintenance Grand mal seizure 
before awakening
·· Unknown—all 
investigations negative
None Uneventful Discharged 
home
Case 5 1y 4m I ·· Awakening/
PACU
Unreported, 
despite query
Unreported Benzodiazepines Psychomotor 
agitation
Discharged 
home
Children with anaphylaxis (n=3) 
Case 1 8y 4m I ·· Maintenance Hypotension ·· Erythromycin 
(confirmed)
Fluid 
resuscitation, 
phenylephrine
Uneventful Discharged 
home
Case 2 9y 9m I ·· PACU Not reported ·· Neostigmine 
(suspected)
Intravenous 
steroids, 
H1 receptor 
antagonist
Uneventful Discharged 
home
Case 3 2y 11m II ·· Maintenance Hypotension ·· Latex allergy
(confirmed)
Epinephrine Admitted to 
intensive care
Discharged 
home
Age is in years (y), months (m), and days (d). One patient (case 3) had two distinguished episodes on two different days. ASA=American Society of Anesthesiology. CCM=closed chest massage. ENT=ear, nose, and 
throat surgery. PACU=post-anaesthesia care unit. DORV=double outlet right ventricle. VSD=ventricular septal defect. ASD=atrial septal defect. ICU=intensive care unit. OCM=open chest massage. SpO₂=pulse 
oximeter oxygen saturation. ACE=angiotensin-converting enzyme. 
Table 5: Details of the children with perioperative cardiac arrest, neurological symptoms, or anaphylaxis
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which imply that the findings are readily general-
isable. However, we cannot infer what happened in 
non-participating centres; since centres voluntarily 
participated in the study, the results might be 
applicable only to the sample of included centres 
across Europe. The participant centres were not aware 
of the outcome of the study because they did not 
perform pre-analysis of their own data. Thus, we can 
declare with confidence that their participation was 
not biased by a personal or institutional moti vation.
We used a validated and uniform definition of the 
recorded adverse events to decrease variations in 
interpretation of a given adverse event. Each definition 
specifically required that a non-planned intervention 
was necessary to treat or reverse the complication. 
Although we cannot completely exclude that some 
occurrences might have been interpreted differently by 
the anaes thesiologist in charge, two independent data 
cleaning procedures generated over 29 000 queries, 
which were sent to the participating centres to ensure 
full objectivity of the reporting. Additionally, all 
complications were reviewed by the two principal 
investigators (WH and FV) independently and details 
were confirmed, when necessary, by the local 
investigators.
Our results show a higher incidence of severe critical 
events than previously reported in the literature.1,2,15,16 
Most of these reports were based on retrospective 
analysis3,6,13 or voluntary self-reporting,5,17,18 which 
might have underestimated paediatric anaesthesia 
morbidity. However, the overall 30-day in-hospital 
mortality in our cohort study was lower than reported 
by de Bruin and colleagues.19 This discrepancy in the 
high incidence of severe critical events and lower 
mortality might be explained in part by the nature of 
the case load and case mix of the institutions involved 
in our study.
There were significant differences in the occurrence 
and nature of severe critical events among participating 
countries (figure 3). Countries were deliberately not 
identified in this report, but we hope the data will form 
the basis for a range of quality improvement initiatives 
across Europe. This need is further substantiated by the 
various non-evidence-based strategies applied to treat a 
given complication (tables 2, 3). Our sample size 
calculation was based on the incidence of severe critical 
events occurring in a dedicated paediatric centre,3 thus 
this study might not be adequately powered to identify 
the risk factors based on individual institutions or to 
study risk factors for specific types of severe critical 
events.
It has been suggested that a low volume of paediatric 
cases might be associated with a higher incidence of 
cardiac arrest;20 in a subgroup analysis of centres 
reporting respiratory and cardiovascular severe critical 
events, there was some evidence for such a relation-
ship, suggesting that the caseload, and potentially the 
experience it provides, could be more relevant than the 
type of institution. The composition of the anaesthesia 
team has been reported to decrease perioperative 
morbidity.21 We found that in more than 55% of cases, 
one single anaesthesiologist performed the anaesthesia 
procedure, which reflects the variable provision in 
Europe of paediatric anaesthesia nurses.22 Never-
theless, the results did not show any difference in the 
incidence of severe critical events when comparing 
size or composition of the anaesthesia team (data not 
shown).
In line with previous studies published in the 
literature, age was found to be a significant risk factor 
for the occurrence of severe critical events.1–3,14,23,24 
Although cardio vascular severe critical events were 
significantly more frequent in neonates (figure 2), 
respiratory severe critical events were more frequent in 
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Figure 2: Distribution of severe critical events throughout the age groups
(A) Relative incidence and of respiratory and cardiovascular events (%) and the relative distribution of the four respiratory 
critical events (%). (B) Age distribution of cardiovascular (orange) and respiratory (blue) critical events.
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infants and pre-school children. There are no accepted 
normative ranges for physiological parameters in 
neonates, so one could expect a higher incidence of 
cardiovascular events, which might affect subsequent 
neurological development.25 An ongoing European 
multicentre clinical trial aims to identify the out-of-
range physiological parameters that lead to unplanned 
therapeutic interventions during anaesthesia manage-
ment in neonates.26
The results of our study reveal a significantly higher 
incidence of both respiratory and cardiac severe critical 
events in children up to 6 years of age. The receiver 
operating characteristic analysis suggests that children 
younger than 3–3·5 years should be managed by 
tertiary care providers or by anaes thesiologists with 
specific paediatric training to reduce the occurrence 
and improve the outcome of peri-anaesthetic severe 
critical events. Identifying an age that might be 
considered as a threshold for allocating children to 
centres with specialist paediatric practices or paediatric 
anaesthesiologists is a matter of debate in many 
European countries and anaesthesia societies.27,28
Although the predictive value and the rating con-
sistency of ASA physical status has been questioned in 
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children,23,29 including it in the risk stratification in this 
study of severe critical events was useful.20,30,31 The 
results of our study show that ASA-PS used alone, or as 
a collapsed variable in addition to the presence of 
history of handicap (including congenital heart 
disease), fever, and snoring, was associated with a 
higher incidence of severe critical events. Considering 
that the role of the anaesthesiologist was relevant 
regarding severe critical events in our study, particularly 
severe cardiovascular instability when ASA-PS was 
greater than III, management of such cases by 
an experienced paediatric anaesthesiologist can be 
recommended.
As expected, snoring appeared as a risk factor for the 
occurrence of severe critical events, independently of 
ear, nose, and throat surgery. This finding highlights 
the importance of recognising the presence of this risk 
factor during the pre-anaesthesia assessment of the 
child.32
In line with previous reports,1 anaesthesia manage-
ment had an important effect on the incidence of 
respiratory severe critical events (table 6). Our results 
highlight an extremely large variability in anaesthesia 
practice in Europe with the use of numerous drug 
combinations and analgesia techniques (appendix 
pp 3–4). There is a need to harmonise paediatric 
anaesthesia management in Europe as illustrated by 
the variety of anaesthesia plans (eg, those regarding 
tracheal intubation). Intubation without muscle 
relaxant significantly in creased the risk for broncho-
spasm, and there was a reassuring absence of reports 
of anaphylaxis associated with muscle relaxants, 
which encourages their more widespread integration 
into clinical guidelines for airway manage ment in 
children.
In summary, the results of the present study provide 
insight into the paediatric anaesthesia practice across 
33 European countries, and allow an estimation of the 
incidence, nature, and outcome of severe critical events 
in the participating centres. While anaphylaxis and 
neurological events occurred rarely, the incidence of 
cardiac arrests was similar to that reported in the 
literature. However, the overall incidence of respiratory 
and cardiac severe critical events was higher than 
previously published, with a large variability among 
the participating centres across Europe. The most 
import ant risk factors for severe critical events are 
young age, medical history, comorbidities, and physical 
Univariate (n=31 127) Multivariate* (n=28 512)
Yes No Relative risk (95% CI); p value Relative risk (95% CI); p value
Total SD or n (%) Total SD or n (%)
Mean age (years) 4·2 3·8 6·4 4·5 0·88 (0·86–0·90); p<0·0001 0·88 (0·86–0·90); p<0·0001
Sex (male vs female) 19 017 542 (2·9%) 12 110 317 (2·6%) 1·09 (0·95–1·25); p=0·21 1·00 (0·88–1·14); p=0·96
Airway sensitivity
Upper respiratory tract 
infection in the past 2 weeks
4200 265 (6·3%) 26 046 582 (2·2%) 2·82 (2·45–3·25); p<0·0001 ··
Wheezing in the past 12 
months
1967 164 (8·3%) 27 398 646 (2·4%) 3·53 (2·99–4·17); p<0·0001 ··
Asthma diagnosis 1886 86 (4·6%) 28 645 764 (2·7%) 1·71 (1·38–2·13); p<0·0001 ··
Passive smoking 3400 128 (3·8%) 18 114 492 (2·7%) 1·39 (1·15–1·69); p=0·00065 ··
Airway sensitivity† 8821 426 (4·8%) 22 058 430 (1·9%) 2·38 (2·09–2·72); p<0·0001 2·23 (1·93–2·57); p<0·0001
Environmental sensitivity
Allergy 3831 112 (2·92%) 27 059 741 (2·7%) 1·07 (0·88–1·30); p=0·49 ··
Atopy 2330 84 (3·6%) 27 362 726 (2·7%) 1·36 (1·09–1·70); p=0·0067 ··
Environmental sensitivity‡ 5203 160 (3·1%) 25 806 697 (2·7%) 1·14 (0·96–1·35); p=0·13 1·09 (0·93–1·28); p=0·27
Physical condition
Prematurity 2363 121 (5·1%) 25 272 666 (2·6%) 1·94 (1·61–2·35); p<0·0001 ··
Fever 904 44 (4·9%) 29 522 801 (2·7%) 1·79 (1·33–2·41); p=0·00012 ··
Handicap 4083 121 (3·0%) 26 672 732 (2·7%) 1·08 (0·90–1·31); p=0·42 ··
Snoring 4429 217 (4·9%) 21 814 510 (2·3%) 2·09 (1·79–2·45); p<0·0001 ··
Medication 7242 222 (3·1%) 23 611 633 (2·7%) 1·15 (0·99–1·33); p=0·077 ··
ASA status (p<0·0001§)
ASA status II 8739 300 (3·4%) 18 883 448 (2·4%) 1·45 (1·25–1·67); p<0·0001 ··
ASA status III-IV-V 3497 111 (3·2%) 18 883 448 (2·4%) 1·34 (1·09–1·65); p=0·0052 ··
Physical condition¶ 14 253 493 (3·5%) 16 872 366 (2·2%) 1·60 (1·40–1·82); p<0·0001 1·21 (1·05–1·39); p=0·0067
Anaesthesia plan
Surgical vs non-surgical 22 225 643 (2·9%) 8902 216 (2·4%) 1·19 (1·02–1·39); p=0·025 ··
(Table 6 continues on next page)
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status. Accordingly, children younger than 3 years and 
those with a medical history including prematurity, 
handicap (metabolic or genetic disorder, or neurological 
impairment), snoring, airway hypersensitivity, and a 
medical condition with fever or under medication are 
at increased risk of severe critical events and should be 
anaesthetised by an adequately experienced anaes-
thesiologist with sufficient paediatric training and 
Univariate (n=31 127) Multivariate* (n=28 512)
Yes No Relative risk (95% CI); p value Relative risk (95% CI); p value
Total SD or n (%) Total SD or n (%)
(Continued from the previous page)
General anaesthesia vs 
sedation
29 064 841 (2·9%) 1961 18 (0·9%) 3·15 (1·98–5·02); p<0·0001 ··
Urgent-emergency vs elective 
anaesthesia
5893 168 (2·9%) 25 232 691 (2·7%) 1·04 (0·88–1·23); p=0·65 ··
After hours 
vs during opening hours
3133 79 (2·5%) 27 993 780 (2·8%) 0·91 (0·72–1·14); p=0·39 ··
Premedication 15 263 420 (2·7%) 15 862 439 (2·8%) 0·99 (0·87–1·13); p=0·91 ··
Inpatient vs outpatient 18 670 590 (3·2%) 12 455 269 (2·2%) 1·46 (1·27–1·69); p<0·0001 ··
Consultation >24 h 18 525 541 (2·9%) 12 600 318 (2·5%) 1·16 (1·01–1·33); p=0·036 ··
Ear-nose-throat surgery 5707 224 (3·9%) 25 412 635 (2·5%) 1·57 (1·35–1·82); p<0·0001 ··
Type of centres (p=0·039§)
Mixed adult-paediatric 
vs paediatric
14 626 440 (3·0%) 12 966 333 (2·6%) 1·14 (0·99–1·31); p=0·071 ··
Community or private 
hospital vs paediatric
3535 86 (2·4%) 12 966 333 (2·6%) 0·92 (0·73–1·16); p=0·49 ··
Anaesthesia team (p=0·045§)
Frequent vs specialist 4359 147 (3·4%) 18 367 476 (2·6%) 1·30 (1·08–1·56); p=0·0047 ··
Occasional vs specialist 5969 169 (2·8%) 18 367 476 (2·6%) 1·10 (0·92–1·30); p=0·30 ··
Trainee vs specialist 2428 67 (2·8%) 18 367 476 (2·6%) 1·07 (0·83–1·37); p=0·62 ··
Type of centres combined with anaesthesia team|| (p=0·98§)
Occasional vs paediatric 6704 187 (2·8%) 21 991 605 (2·8%) 1·02 (0·86–1·20); p=0·84 ··
Trainee vs paediatric 2428 67 (2·8%) 21991 605 (2·8%) 1·00 (0·78–1·29); p=0·97 ··
Years of experience of most 
senior team member
13·85 9·0 14·80 9·4 0·989 (0·982–0·996); 
p=0·0029
0·99 (0·981–0·997); 
p=0·0048
Anaesthesia plan** 27 119 793 (2·9%) 4008 66 (1·6%) 1·72 (1·34–2·21); p<0·0001 1·46 (1·12–1·89); p=0·0047
Anaesthesia management
Induction type (intravenous vs 
inhalation)†† 
13 906 303 (2·2%) 15 105 538 (3·6%) 0·85 (0·74–0·98); p=0·024 0·78 (0·66–0·93); p=0·0043
Interface for airway 
management
·· ·· ·· ·· <0·0001§ <0·0001
ETT vs facial mask 13 671 554 (4·1%) 4970 61 (1·2%) 3·31 (2·54–4·30); p<0·0001 3·36 (2·41–4·67); p<0·0001 
SGAW vs facial mask 10 919 223 (2·0%) 4970 61 (1·2%) 1·67 (1·26–2·21); p=0·00036 2·00 (1·40–2·85); p=0·0001
Other vs facial mask 573 16 (2·8%) 4970 61 (1·2%) 2·29 (1·33–3·95); p=0·0028 2·65 (1·49–4·74); p=0·0001 
Rapid sequence 1372 37 (2·7%) 12 295 516 (4·2%) 0·64 (0·46–0·89); p=0·0084 ··
Uncuffed vs cuffed 3843 169 (4·4%) 9828 386 (3·9%) 1·12 (0·94–1·34); p=0·21 ··
Monitored cuff pressure 4667 201 (4·3%) 5144 184 (3·6%) 1·20 (0·99–1·46); p=0·063 ··
Vocal cords sprayed 1134 56 (4·9%) 12 535 498 (4·0%) 1·24 (0·95–1·63); p=0·11 ··
Deep vs awake extubation 3562 167 (4·7%) 9370 367 (3·9%) 1·20 (1·00–1·43); p=0·049 ··
Deep vs awake removal SGAW 4600 107 (2·3%) 6211 114 (1·8%) 1·26 (0·97–1·63); p=0·089 ··
Myorelaxant for intubation 8382 305 (3·6%) 5284 248 (4·7%) 0·78 (0·66–0·91); p=0·0023 ··
ASA=American Society of Anesthesiology. ETT=endotracheal intubation. SGAW=supraglottic airway. *Variables in the multivariate model: age, gender, airway sensitivity, 
environmental sensitivity, physical condition, anaesthesia plan, years of experience of senior person, induction type, interface for airway management. †Airway sensitivity: 
upper respiratory tract infection in the past 2 weeks, wheezing, asthma, or passive smoking. ‡Allergy or atopy. §The overall effect of a categorical variable on the risk of severe 
respiratory critical events. ¶Prematurity, fever, handicap, snoring, medication, or ASA status greater than II. ||Paediatric: all specialist and frequent in paediatric or mixed 
hospital; occasional: all occasional and frequent in community or private institution. **Urgent or emergency, after hours, inpatient, consultation >24 h, or ear, nose, and 
throat surgery. ††Adjusted for age. 
Table 6: Relative risk and 95% CIs for the risk factors associated with the occurrence for severe respiratory critical events (perioperative laryngospasm, 
bronchospasm, or postoperative stridor)
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ongoing paediatric experience or, if possible, post-
poned. The findings from APRICOT will help 
local in sti tutions and national societies to establish 
Univariate (n=31 127) Multivariate* (n=31 062)
Yes No RR (95% CI); p value RR (95% CI); p value
Total SD or n (%) Total SD or n (%)
Mean age (years) 5·96 5·6 6·35 4·5 0·99 (0·96–1·01); p=0·11 0·99 (0·97–1·02); p=0·568
Sex (male) 19 017 319 (1·7%) 12 110 275 (2·3%) 0·74 (0·63–0·87); p<0·0001 0·74 (0·64–0·87); p=0·0002
Physical condition
Prematurity 2363 92 (3·9%) 25 272 437 (1·7%) 2.24 (1·79–2·80); p<0·0001 ..
Fever 904 23 (2·5%) 29 522 556 (1·9%) 1.32 (0·86–2·03); p=0·20 ..
Handicap 4083 153 (3·8%) 26 672 434 (1·6%) 2·33 (1·94–2·79); p<0·0001 ..
Medication 7242 241 (3·3%) 23 611 345 (1·5%) 2·26 (1·92–2·67); p<0·0001 ..
ASA status II 8739 169 (1·9%) 18 883 191 (1·0%) 1·90 (1·55–2·34); p<0·0001 ..
ASA status III-IV-V 3497 233 (6·7%) 18 883 191 (1·0%) 6·56 (5·44–7·92); p<0·0001 ..
Physical condition† 11 526 383 (3·3%) 19 599 211 (1·1%) 3·07 (2·60–3·63); p<0·0001 2·65 (2·20–3·19); p<0·0001
Surgical and anaesthesia plans
Surgical vs non-surgical 22 225 516 (2·3%) 8902 78 (0·9%) 4·20 (3·22–5·49); p<0·0001 ..
General anaesthesia 
vs sedation
29 064 587 (2·0%) 1961 5 (0·3%) 8·30 (3·56–19·35); p<0·0001 ..
Urgent-emergency vs 
elective anaesthesia 
5893 161 (2·7%) 25 232 433 (1·7%) 1·54 (1·28–1·865); p<0·0001 ..
After hours vs opening 
hours
3133 52 (1·7%) 27 993 542 (1·9%) 0·80 (0·58–1·09); p=0·16 ..
Premedication 15 263 267 (1·8%) 15 862 327 (2·1%) 0·86 (0·73–1·01); p=0·067 ..
Inpatient vs outpatient 18 670 519 (2·8%) 12 455 75 (0·6%) 4·54 (3·57–5·78); p<0·0001 ..
Consultation >24 h 18 525 415 (2·2%) 12 600 179 (1·4%) 1·53 (1·25–1·88); p<0·0001 ..
Cardiac surgery 256 74 (28·9%) 30 863 520 (1·7%) 16·92 (13·67–20·93); p<0·0001 ..
Cardiac catheterism 243 18 (7·4%) 30 882 576 (1·9%) 3·20 (1·71–5·85); p<0·0001 1·85 (1·17–2·92); p=0·0088
Type of centres (p=0·0091‡)
Mixed adult-paediatric/
paediatric
14 626 291 (2·0%) 12 966 260 (2·0%) 0·99 (0·84–1·17); p=0·94 ..
Community private 
hospital/paediatric
3535 43 (1·2%) 12 966 260 (2·0%) 0·62 (0·45–0·85); p=0·003 ..
Anaesthesia team§ (p=0·027‡)
Frequent vs specialist 4359 79 (1·8%) 18 367 371 (2·0%) 0·87 (0·68–1·11); p=0·26 ..
Occasional vs specialist 5969 119 (2·0%) 18 367 371 (2·0%) 0·99 (0·79–1·21); p=0·83 ..
Trainee vs specialist 2428 25 (1·0%) 18 367 371 (2·0%) 0·50 (0·31–0·79); p=0·004 ..
Type of centres combined with anaesthesia team¶ (p=0·013‡)
Occasional vs paediatric 6704 129 (1·9%) 21 991 440 (2·0%) 0·96 (0·79–1·17); p=0·69 0·96 (0·73–1·25); p=0·741
Trainee vs paediatric 2428 25 (1·0%) 21 991 440 (2·0%) 0·50 (0·32–0·80); p=0·003 0·43 (0·28–0·67); p=0·0002
Years of experience of most 
senior team member
13·98 8·9 14·79 9·4 0·99 (0·98–1·00); p=0·052 0·98 (0·97–0·99); p=0·0039
Anaesthesia plan|| 28 480 582 (2·04%) 2647 12 (0·45%) 4·085 (2·27–7·35); p<0·0001 4·65 (2·27–9·55); p<0·0001
Anaesthesia management
Induction type 
(intravenous vs inhalation)
13 906 295 (2·1%) 15 105 291 (1·9%) 0·99 (0·80–1·24); p=0·98 ..
Myorelaxant 8382 361 (4·3%) 5284 125 (2·4%) 2·34 (0·88–6·20); p=0·087 ..
Rapid sequence 1372 52 (3·8%) 12 295 434 (3·5%) 1·01 (0·32–3·22); p=0·98 ..
ASA=American Society of Anesthesiology. *Variables in the multivariate model: age, gender, airway sensitivity, environmental sensitivity, physical condition, 
anaesthesia plan, years of experience of senior person, induction type, interface for airway management †Prematurity, fever, handicap, medication, or ASA status 
greater than II. ‡The overall effect of a categorical variable on the risk of cardiovascular instability. §Paediatric specialist as reference value. ¶Paediatric: all specialist and 
frequent in paediatric or mixed hospital; occasional: all occasional and frequent in community or private institution. ||Urgent or emergency, after hours, premedication, 
inpatient, or consultation >24 h.
Table 7: Relative risk and 95% CIs for the risk factors associated with the occurrence of perioperative cardiovascular instability
standards of care and implement patient safety and 
quality improvement projects aimed at reducing the 
risk of severe critical events.
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